Original Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 14, 2013; 19(26): 4155-4165
Published online Jul 14, 2013. doi: 10.3748/wjg.v19.i26.4155
Figure 2
Figure 2 Effect of downregulation of CDX2 on cell pump rate of doxorubicin, cell cycle, and apoptotic rate in SGC7901/DDP cells after RNA interference. A, B: Pump rate of doxorubicin in SGC7901/DDP cells after RNAi was analyzed by flow cytometry; C, D: Cell cycle in SGC7901/DDP cells after RNAi was analyzed by flow cytometry; E, F: Apoptotic rate in SGC7901/DDP cells after RNAi was analyzed by flow cytometry. aP < 0.05 for SGC7901/DDP + small interfering RNA (siRNA)-CDX2 cells vs SGC7901/DDP + siRNA-NC cells and SGC7901/DDP cells. Lane 1: SGC7901/DDP + siRNA-CDX2 cells; Lane 2: SGC7901/DDP + siRNA-NC cells; Lane 3: SGC7901/DDP cells.